Aug 18, 2021 7:10am EDT ProMIS Neurosciences Inc. Announces Pricing of US$15 Million Public Offering of Units
Jul 22, 2021 7:15am EDT ProMIS Neurosciences to Present at 2021 Alzheimer’s Association International Conference
Jun 08, 2021 7:30am EDT ProMIS Neurosciences congratulates Biogen on FDA accelerated approval of aducanumab for Alzheimer’s disease
May 27, 2021 7:30am EDT ProMIS Neurosciences appoints renowned scientist, Dr. David Wishart as Chief Physics Officer